1168 related articles for article (PubMed ID: 19553350)
1. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells.
Yoshikawa M; Hishikawa K; Marumo T; Fujita T
J Am Soc Nephrol; 2007 Jan; 18(1):58-65. PubMed ID: 17135397
[TBL] [Abstract][Full Text] [Related]
3. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat.
Khan S; Jena G; Tikoo K
Exp Mol Pathol; 2015 Apr; 98(2):230-9. PubMed ID: 25576297
[TBL] [Abstract][Full Text] [Related]
4. Role of reactive oxygen species in transforming growth factor-beta1-induced extracellular matrix accumulation in renal tubular epithelial cells.
Rhyu DY; Park J; Sharma BR; Ha H
Transplant Proc; 2012 Apr; 44(3):625-8. PubMed ID: 22483454
[TBL] [Abstract][Full Text] [Related]
5. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L
Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996
[TBL] [Abstract][Full Text] [Related]
6. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures.
Cho JS; Moon YM; Park IH; Um JY; Kang JH; Kim TH; Lee SH; Kang HJ; Lee HM
Am J Rhinol Allergy; 2013 Jan; 27(1):18-23. PubMed ID: 23406592
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy.
Wang X; Liu J; Zhen J; Zhang C; Wan Q; Liu G; Wei X; Zhang Y; Wang Z; Han H; Xu H; Bao C; Song Z; Zhang X; Li N; Yi F
Kidney Int; 2014 Oct; 86(4):712-25. PubMed ID: 24717296
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
Park JH; Hwang I; Hwang SH; Han H; Ha H
Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
[TBL] [Abstract][Full Text] [Related]
9. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
[TBL] [Abstract][Full Text] [Related]
11. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition.
Park SH; Choi MJ; Song IK; Choi SY; Nam JO; Kim CD; Lee BH; Park RW; Park KM; Kim YJ; Kim IS; Kwon TH; Kim YL
J Am Soc Nephrol; 2007 May; 18(5):1497-507. PubMed ID: 17389738
[TBL] [Abstract][Full Text] [Related]
13. Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury.
Park JH; Park J; Hwang SH; Han H; Ha H
Transplant Proc; 2012 May; 44(4):1123-6. PubMed ID: 22564642
[TBL] [Abstract][Full Text] [Related]
14. β-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells.
Zhang W; Miao J; Ma C; Han D; Zhang Y
Peptides; 2012 Aug; 36(2):186-91. PubMed ID: 22687367
[TBL] [Abstract][Full Text] [Related]
15. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
Cho JS; Moon YM; Park IH; Um JY; Moon JH; Park SJ; Lee SH; Kang HJ; Lee HM
Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.
Zhou L; Xue H; Yuan P; Ni J; Yu C; Huang Y; Lu LM
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):e152-7. PubMed ID: 20590668
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
Lin Y; Sun Z
J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121
[TBL] [Abstract][Full Text] [Related]
19. Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats.
Surse VM; Gupta J; Tikoo K
J Mol Endocrinol; 2011 Jun; 46(3):245-54. PubMed ID: 21450970
[TBL] [Abstract][Full Text] [Related]
20. Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells.
Choi SY; Kee HJ; Kurz T; Hansen FK; Ryu Y; Kim GR; Lin MQ; Jin L; Piao ZH; Jeong MH
J Cell Mol Med; 2016 Dec; 20(12):2289-2298. PubMed ID: 27420561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
